FORMULA 22158

Main information

  • Trade name:
  • FORMULA 22158 CAPSULE
  • Dosage:
  • 9MG; 4MG; 161MG; 21MG; 7MG; 14MG; 7MG; 7MG
  • Pharmaceutical form:
  • CAPSULE
  • Composition:
  • CHOLINE BITARTRATE 9MG; MAGNESIUM GLYCEROPHOSPHATE 4MG; CALCIUM GLYCEROPHOSPHATE 161MG; BETAINE HYDROCHLORIDE 21MG; GLUTAMIC ACID HYDROCHLORIDE 7MG; POTASSIUM BICARBONATE 14MG; AMMONIUM CHLORIDE 7MG; CALCIUM CHLORIDE 7MG
  • Administration route:
  • ORAL
  • Units in package:
  • 60
  • Prescription type:
  • OTC
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FORMULA 22158 CAPSULE
    Canada
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • MINERALS
  • Product summary:
  • Active ingredient group (AIG) number: 0800918001; AHFS: 88:29.00

Other information

Status

  • Source:
  • Health Canada
  • Authorization status:
  • MARKETED
  • Authorization number:
  • 00191531
  • Authorization date:
  • 18-05-1994
  • Last update:
  • 12-01-2019

There are no safety alerts related to this product.

18-12-2018


Calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide: List of nationally authorised medicinal products - PSUSA/00010390/201801

Calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide: List of nationally authorised medicinal products - PSUSA/00010390/201801

Calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide: List of nationally authorised medicinal products - PSUSA/00010390/201801

Europe - EMA - European Medicines Agency

27-11-2018


Opinion/decision on a Paediatric investigation plan (PIP): Fibrinogen,thrombin,aprotinin,calcium chloride, decision type: , therapeutic area: , PIP number: P/0199/2018

Opinion/decision on a Paediatric investigation plan (PIP): Fibrinogen,thrombin,aprotinin,calcium chloride, decision type: , therapeutic area: , PIP number: P/0199/2018

Opinion/decision on a Paediatric investigation plan (PIP): Fibrinogen,thrombin,aprotinin,calcium chloride, decision type: , therapeutic area: , PIP number: P/0199/2018

Europe - EMA - European Medicines Agency

22-11-2018


Opinion/decision on a Paediatric investigation plan (PIP): Citric acid (as citric acid anhydrous) / sodium chloride / simeticone / macrogol 4000 / sodium citrate /sodium sulfate (as sodium sulfate anhydrous) / potassium chloride (PMF104), decision type:

Opinion/decision on a Paediatric investigation plan (PIP): Citric acid (as citric acid anhydrous) / sodium chloride / simeticone / macrogol 4000 / sodium citrate /sodium sulfate (as sodium sulfate anhydrous) / potassium chloride (PMF104), decision type:

Opinion/decision on a Paediatric investigation plan (PIP): Citric acid (as citric acid anhydrous) / sodium chloride / simeticone / macrogol 4000 / sodium citrate /sodium sulfate (as sodium sulfate anhydrous) / potassium chloride (PMF104), decision type: , therapeutic area: , PIP number: P/0223/2018

Europe - EMA - European Medicines Agency